Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics

Overview
This study explores nano-radiomics to assess response to MDSC-directed NK cell therapy in solid tumors. Human NK cells were activated and expanded in G-Rex® devices for in vivo testing. Radiomic analysis of CT images successfully identified treatment responses that conventional tumor metrics failed to detect.
What this paper found
Radiomic analysis of nanoparticle contrast-enhanced images detected the effect of cellular immunotherapy aimed at the tumor microenvironment, where conventional tumor measurements did not. In a mouse neuroblastoma xenograft containing human myeloid-derived suppressor cells (MDSCs), NKG2D.ζ-modified NK cells depleted intratumoral MDSCs and lowered vessel density, yet CT-derived tumor volume, attenuation and fractional blood volume did not differ between groups. Of 107 radiomic features, 91 were tested; 10 features from delayed CT, 13 from CT angiography and 5 from T2-weighted MRI separated treated from untreated tumors, mainly GLSZM and GLRLM texture features. The work is preclinical.
Note: Preclinical mouse xenograft study; the authors note that the predictive power of radiomic features for tumor response has not been evaluated and that scan-parameter effects need further investigation.
Our study shows that TME-directed cellular immunotherapy causes subtle changes not effectively gauged by conventional imaging metrics but revealed by nano-radiomics. — Laxman Devkota, Zbigniew Starosolski, Charlotte H. Rivas, Igor Stupin, Ananth Annapragada, Ketan B. Ghaghada, Robin Parihar, Science Advances
Study details
- Authors
- Laxman Devkota, Zbigniew Starosolski, Charlotte H. Rivas, Igor Stupin, Ananth Annapragada, Ketan B. Ghaghada, Robin Parihar
- Institution
- Singleton Department of Pediatric Radiology, Texas Children's Hospital, Houston, TX, USA · Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA · Department of Radiology, Baylor College of Medicine, Houston, TX, USA · Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, TX, USA
- Journal
- Science Advances
- Year
- 2020
- Cell type(s)
- NK Cells
- Application area
- Solid tumor
- Study phase
- Preclinical
How G-Rex® was used
G-Rex® cell culture devices were used to expand and activate human NK cells before gene modification. Healthy-donor PBMCs were cocultured with irradiated K562-mb15-41BB-L feeder cells at a 1:10 NK cell to irradiated tumor cell ratio for 4 days in Stem Cell Growth Medium with 10% FBS and IL-2 at 500 IU/ml. After retroviral transduction, cells were expanded again in G-Rex® devices at the same ratio with IL-2 at 100 IU/ml. The 17-day protocol gave a more than 95% pure CD56+/CD3- NK population, with an average of 72.1% of NK cells transduced.
Note: The expanded NKG2D.ζ NK cells were the TME-directed therapy infused into the xenograft mice.
Explore related
Full citation
Devkota L, Starosolski Z, Rivas CH, et al. Detection of response to tumor microenvironment–targeted cellular immunotherapy using nano-radiomics. Sci Adv. 2020;6(28):eaba6156.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.